Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat
Condition(s):Sickle Cell Disease; Hemolytic AnemiaLast Updated:September 29, 2023Active, not recruiting